SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-065123
Filing Date
2020-05-22
Accepted
2020-05-22 08:27:36
Documents
9
Period of Report
2020-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2020053-3_8k.htm 8-K 21678
2 EXHIBIT 1.1 tm2020053d3_ex1-1.htm EX-1.1 271016
3 EXHIBIT 5.1 tm2020053d3_ex5-1.htm EX-5.1 15506
4 EXHIBIT 99.1 tm2020053d3_ex99-1.htm EX-99.1 18336
5 EXHIBIT 99.2 tm2020053d3_ex99-2.htm EX-99.2 20071
6 GRAPHIC tm2020053d3_ex5-1img001.jpg GRAPHIC 5745
7 GRAPHIC tm2020053d3_ex5-1img002.jpg GRAPHIC 27483
8 GRAPHIC tm2020053d3_ex99-1img01.jpg GRAPHIC 18484
9 GRAPHIC tm2020053d3_ex99-1img02.jpg GRAPHIC 3941
  Complete submission text file 0001104659-20-065123.txt   425122
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36554 | Film No.: 20903719
SIC: 2834 Pharmaceutical Preparations